AU2001264044A1 - 1,4-diazabicyclo(3.2.2)nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof - Google Patents
1,4-diazabicyclo(3.2.2)nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereofInfo
- Publication number
- AU2001264044A1 AU2001264044A1 AU2001264044A AU6404401A AU2001264044A1 AU 2001264044 A1 AU2001264044 A1 AU 2001264044A1 AU 2001264044 A AU2001264044 A AU 2001264044A AU 6404401 A AU6404401 A AU 6404401A AU 2001264044 A1 AU2001264044 A1 AU 2001264044A1
- Authority
- AU
- Australia
- Prior art keywords
- nonabenzoxazole
- benzothiazole
- diazabicyclo
- preparation
- therapeutic use
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0006975A FR2809730B1 (fr) | 2000-05-31 | 2000-05-31 | Derives de 1,4-diazabicyclo[3.2.2] nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique |
FR0006975 | 2000-05-31 | ||
PCT/FR2001/001651 WO2001092261A1 (fr) | 2000-05-31 | 2001-05-29 | Derives de 1,4-diazabicyclo [3.2.2]nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001264044A1 true AU2001264044A1 (en) | 2001-12-11 |
Family
ID=8850826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001264044A Abandoned AU2001264044A1 (en) | 2000-05-31 | 2001-05-29 | 1,4-diazabicyclo(3.2.2)nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof |
Country Status (11)
Country | Link |
---|---|
US (1) | US7220740B2 (fr) |
EP (1) | EP1289988B1 (fr) |
JP (1) | JP4939721B2 (fr) |
AR (1) | AR028647A1 (fr) |
AT (1) | ATE267202T1 (fr) |
AU (1) | AU2001264044A1 (fr) |
DE (1) | DE60103395T2 (fr) |
FR (1) | FR2809730B1 (fr) |
HU (1) | HU229102B1 (fr) |
TW (1) | TW541307B (fr) |
WO (1) | WO2001092261A1 (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0000540D0 (sv) | 2000-02-18 | 2000-02-18 | Astrazeneca Ab | New compounds |
US20020086871A1 (en) * | 2000-12-29 | 2002-07-04 | O'neill Brian Thomas | Pharmaceutical composition for the treatment of CNS and other disorders |
MXPA04000012A (es) * | 2001-07-06 | 2004-05-21 | Neurosearch As | Compuestos novedosos, su preparacion y uso. |
FR2832714B1 (fr) | 2001-11-23 | 2004-07-16 | Sanofi Synthelabo | Derives de 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo[3.2.2] nonane, leur preparation et leur application en therapeutique |
SE0202465D0 (sv) * | 2002-08-14 | 2002-08-14 | Astrazeneca Ab | New compounds |
FR2845388B1 (fr) * | 2002-10-08 | 2004-11-12 | Sanofi Synthelabo | Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique |
US7456171B2 (en) | 2002-10-08 | 2008-11-25 | Sanofi-Aventis | 1,4-Diazabicyclo[3.2.2]nonanecarboxamide derivatives, preparation and therapeutic use thereof |
JP2006508109A (ja) * | 2002-11-11 | 2006-03-09 | ニューロサーチ、アクティーゼルスカブ | 1,4−ジアザビシクロ(3,2,2)ノナン誘導体、その製造方法及びその使用 |
US7223753B2 (en) | 2002-11-11 | 2007-05-29 | Neurosearch A/S | Diazabicyclic biaryl derivatives |
NZ540998A (en) * | 2003-02-27 | 2008-06-30 | Neurosearch As | Novel diazabicyclic aryl derivatives |
FR2865208B1 (fr) * | 2004-01-16 | 2009-01-16 | Sanofi Synthelabo | Derives de 1,4-diazabicyclo[3.2.1]octanecarboxmique, leur preparation et leur application en therapeutique |
KR20060125885A (ko) | 2004-02-04 | 2006-12-06 | 뉴로서치 에이/에스 | 콜린 수용체 조절제로서의 디아자바이사이클릭 아릴 유도체 |
WO2006051410A1 (fr) * | 2004-11-15 | 2006-05-18 | Pfizer Inc. | Azabenzoxazoles pour le traitement de troubles du systeme nerveux central |
WO2006051413A1 (fr) * | 2004-11-15 | 2006-05-18 | Pfizer Inc. | Azabenoxazoles dans le traitement des troubles du snc |
WO2006051407A1 (fr) * | 2004-11-15 | 2006-05-18 | Pfizer Products Inc. | Azabenzoxazoles pour le traitement des troubles du systeme nerveux central |
US7662812B2 (en) | 2005-02-16 | 2010-02-16 | Neurosearch A/S | Diazabicyclic aryl derivatives and their use as chinolinergic ligands at nicotinic acetylcholine receptors |
WO2007135121A1 (fr) | 2006-05-23 | 2007-11-29 | Neurosearch A/S | Nouveaux dérivés de 8,10-diaza-bicyclo[4.3.1]décane et leur utilisation médicale |
CN104262348B (zh) * | 2014-08-15 | 2017-12-15 | 北京师范大学 | 一种α7烟碱型乙酰胆碱受体配体及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN166416B (fr) * | 1985-09-18 | 1990-05-05 | Pfizer | |
NZ226000A (en) * | 1987-09-10 | 1991-06-25 | Merck Sharp & Dohme | Oxadiazolyl-azabicycloheptanes and pharmaceutical compositions |
US5478939A (en) * | 1994-07-20 | 1995-12-26 | American Cyanamid Company | (R,R) and (S,S) 2,5-diazabicyclo [2,2,1]heptane derivatives |
FR2786770B1 (fr) | 1998-12-04 | 2001-01-19 | Synthelabo | Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique |
US20020086871A1 (en) * | 2000-12-29 | 2002-07-04 | O'neill Brian Thomas | Pharmaceutical composition for the treatment of CNS and other disorders |
-
2000
- 2000-05-31 FR FR0006975A patent/FR2809730B1/fr not_active Expired - Fee Related
-
2001
- 2001-05-29 AU AU2001264044A patent/AU2001264044A1/en not_active Abandoned
- 2001-05-29 AT AT01938363T patent/ATE267202T1/de not_active IP Right Cessation
- 2001-05-29 DE DE60103395T patent/DE60103395T2/de not_active Expired - Lifetime
- 2001-05-29 EP EP01938363A patent/EP1289988B1/fr not_active Expired - Lifetime
- 2001-05-29 HU HU0302193A patent/HU229102B1/hu not_active IP Right Cessation
- 2001-05-29 US US10/276,646 patent/US7220740B2/en not_active Expired - Lifetime
- 2001-05-29 WO PCT/FR2001/001651 patent/WO2001092261A1/fr active IP Right Grant
- 2001-05-29 JP JP2002500874A patent/JP4939721B2/ja not_active Expired - Fee Related
- 2001-05-30 AR ARP010102574A patent/AR028647A1/es active IP Right Grant
- 2001-05-30 TW TW090113060A patent/TW541307B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HUP0302193A3 (en) | 2012-02-28 |
AR028647A1 (es) | 2003-05-21 |
FR2809730A1 (fr) | 2001-12-07 |
EP1289988B1 (fr) | 2004-05-19 |
ATE267202T1 (de) | 2004-06-15 |
EP1289988A1 (fr) | 2003-03-12 |
HUP0302193A2 (hu) | 2003-11-28 |
JP2003535091A (ja) | 2003-11-25 |
DE60103395T2 (de) | 2005-06-16 |
HU229102B1 (en) | 2013-07-29 |
JP4939721B2 (ja) | 2012-05-30 |
TW541307B (en) | 2003-07-11 |
FR2809730B1 (fr) | 2002-07-19 |
WO2001092261A1 (fr) | 2001-12-06 |
US20030153574A1 (en) | 2003-08-14 |
US7220740B2 (en) | 2007-05-22 |
DE60103395D1 (de) | 2004-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1053118A1 (en) | Benzimidazole derivatives, preparation and therapeutic use thereof. | |
HK1061679A1 (en) | Phenylsulfonyl-1,3-dihydro-2h-indole-2-ibe derivatives, their preparation and their therapeutic use. | |
AU2002340999A1 (en) | Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use | |
AU1393000A (en) | 1,4-diazabicyclo(3.2.2)nonane derivatives, their preparation and therapeutic application | |
AU3957600A (en) | Piperidyl-imidazole derivatives, their preparations and therapeutic uses | |
AU2922600A (en) | Pyridopyranoazepine derivatives, preparation and therapeutic use | |
AU2001264044A1 (en) | 1,4-diazabicyclo(3.2.2)nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof | |
AU2002359126A1 (en) | Benzodiazepine derivatives, preparation thereof and use thereof | |
AU2001264042A1 (en) | 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof | |
AU2001235595A1 (en) | 4-heteroaryl-1,4-diazabicyclo(3.2.2)nonane, preparation and therapeutic use thereof | |
AU2002359123A1 (en) | Benzodiazepine derivatives, preparation thereof and use thereof | |
ZA200003706B (en) | Cyclobutene derivatives, their preparation and their therapeutic uses. | |
TWI318974B (en) | Acylaminothiazole derivatives, their preparation and their therapeutic use | |
ZA200001746B (en) | 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use. | |
TWI320413B (en) | 1,4-diazabicyclo [ 3.2.2 ] nonanecarboxamide derivatives, preparation thereof and therapeutic use thereof | |
AU2001284084A1 (en) | Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof | |
MXPA03006162A (es) | Derivados de mikanolida, su preparacion y sus usos terapeuticos. | |
AU2002229870A1 (en) | Mikanolide derivatives, their preparation and therapeutic uses | |
ZA200001747B (en) | 3-Amino-3-arylpropan-1-ol derivatives, their preparation and use. | |
IL161859A0 (en) | 3-Heteroaryl-3.5-dihydro-4-oxo-4H-pyridazinoÄ4.5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use | |
AU2001237518A1 (en) | Polyfluoroalkylimidazole derivatives, their preparation and therapeutic application | |
AU2001278550A1 (en) | 1-(4-oxo-3,5-dihydro-4h-pyridazino(4,5-b)indole-1-carbonyl (piperazine) derivatives, their preparation and therapeutic application | |
IL149653A0 (en) | 2-arylquinoline derivatives, preparation and therapeutic use thereof | |
SI1309594T1 (en) | Benzimidazole derivatives, preparation and therapeutic use thereof | |
AU2001237517A1 (en) | Haloimidazole derivatives, their preparation and therapeutic use |